Hepatitis-b Sentence Examples

The vaccine is designed to prevent diphtheria, tetanus, pertussis, hepatitis B and polio.

As with Kawasaki disease, various infectious organisms have been proposed as the cause of IPAN, including hepatitis B virus, Epstein-Barr virus (EBV), various retroviruses, streptococci, and even a virus usually found in cats.

Testing the blood of a person who has been bitten for immunity to hepatitis B and other diseases is always necessary after a human bite.

A person who has been bitten may also require immunization against hepatitis B and other diseases.

Children who have had a severe allergic reaction to baker's yeast should not take the hepatitis B vaccine.

Hepatitis B is a liver disease caused by the hepatitis B virus (HBV).

It is estimated that hepatitis B accounts for 20 to 25 percent of all acute viral hepatitis in children.

The test detects one of the viral antigens called hepatitis B surface antigen (HBsAg) in the blood.

Later on, HBsAg may no longer be present, in which case a test for antibodies to a different antigen, called hepatitis B core antigen, is used.

If HBsAg can be detected in the blood for longer than six months, chronic hepatitis B is diagnosed.

There is no cure for hepatitis B and no specific treatment is available.

Chronic, or relapsing, infection occurs with hepatitis B in about 5-10 percent of cases.

A vaccine for hepatitis B is as of 2004 widely used in the United States for routine childhood immunization.

If mothers have HBV in their blood, they can give hepatitis B to their baby during childbirth.

If the blood test is positive, the baby should receive vaccine along with hepatitis B immune globulin (HBIG) at birth.

Hepatitis B virus (HBV)-Also called Hepadna virus, the pathogen responsible for hepatitis B infection.

See also Hepatitis A; Hepatitis B vaccine; Vaccination.

Tattoos can lead to the transmission of infectious diseases, such as hepatitis B and C and theoretically HIV, when proper sterilization and safety procedures are not followed.

Body piercing also presents the risk of chronic infection, scarring, hepatitis B and C, tetanus, and skin allergies to the jewelry that is used.

If hepatitis B or C is confirmed, a series of diet and lifestyle changes, such as the elimination of alcohol, is recommended to control the disease.

Minor infections respond well to antibiotic therapy, while blood-borne diseases such as hepatitis B and C cause life-altering results.

Finally, if the hepatitis B vaccine was not given in the hospital, the first shot may be given at this visit.

It the mother of a newborn carries the hepatitis B virus (HBV) in her blood, the baby needs to receive the first shot within 12 hours of birth.

If the hepatitis B injection was not completed at the six month visit, it will be given at this exam.

Approximately 20,000 infants are born each year to mothers who test positive for the hepatitis B virus.

These infants are at high risk for developing hepatitis B infection through exposure to their mothers blood during delivery.

Hepatitis B can be identified through a blood test for the hepatitis B surface antigen (HBsAg) in pregnant women.

All infants should also receive a series of three hepatitis B vaccine injections as part of their routine immunizations.

Infants infected with hepatitis B develop a chronic, mild form of hepatitis and are at increased risk for developing liver disease.

The hepatitis B vaccine (HBV or HepB) is an injection that protects children from contracting hepatitis B, a serious disease caused by the hepatitis B virus.

The hepatitis B vaccine consists of a small protein from the surface of the hepatitis B virus called the hepatitis B surface antigen (HBsAg).

An HBV derived from the blood serum of people with hepatitis B was as of 2004 no longer produced in the United States.

D virus, which occurs as a co-infection with hepatitis B and usually results in more severe disease symptoms.

The duration of hepatitis B immunity following infant vaccination is not known.

A 2004 study found that most low-risk children vaccinated at birth did not have antibodies against hepatitis B in their blood by the time they reached the age of five.

The U.S. Centers for Disease Control and Prevention (CDC) estimates that, prior to the launch of the infant HBV immunization program, about 33,000 American children of non-infected mothers acquired hepatitis B by the age of ten.

Hepatitis B is a potentially serious disease caused by the hepatitis B virus.

The hepatitis B virus is eventually cleared from the bodies of most infected adolescents and adults.

Only about 2-6 percent of infected older children and adults develop chronic hepatitis B and can continue to transmit the virus to other people.

There is no cure for hepatitis B and approximately one-fourth of chronic hepatitis B victims die of cirrhosis or liver cancer, including children who do not survive to young adulthood.

Children under the age of five who become infected with hepatitis B are at high risk for chronic infection and severe liver damage and disease later in life, even though initially they may have no symptoms.

These infected children have a 90 percent risk of chronic hepatitis B infection and as many as 25 percent of them will die of chronic liver disease as adults.

Mothers who have emigrated from countries with high rates of endemic hepatitis B are more likely to be infected.

Mothers with acute or chronic infectious hepatitis B can be identified by a blood test for HBsAg.

Children born to mothers who have hepatitis B or whose hepatitis B status is unknown should receive their first HBV dose within 12 hours of birth.

In many parts of the world, vaccine intervention before birth is required to prevent hepatitis B infection and its consequences in newborns.

It is recommended that newborns whose mothers are HBsAg-positive receive hepatitis B immune globulin (HBIG)-a preparation of serum containing high levels of antibodies to hepatitis B-as well as HBV within 12 hours of birth.

A child's immune response to either hepatitis B infection or to HBV can be measured by a blood test for antibodies to HBsAg (anti-HBs).

Between 1979 and 1989, the incidence of acute hepatitis B increased in the United States by 37 percent.

In 1991 the CDC developed a strategy for eliminating the transmission of hepatitis B via universal childhood vaccination.

Nearly all states enacted laws requiring hepatitis B vaccination for enrollment in daycare, schools, and colleges.

Infant death from hepatitis B and the incidence of liver disease in children also decreased significantly.

The CDC expects the overall incidence of hepatitis B in the American population to fall throughout the early 2000s as a result of mass childhood vaccination.

However, as of 2004, infants receiving HBV since 1991 had not yet reached the age when high-risk behaviors increase the likelihood of hepatitis B infection.

In Pacific Island nations-where rates of hepatitis B infection are among the highest in the world-a regionally coordinated immunization program has significantly reduced the incidence of chronic infection.

In the United States the Vaccines for Children program covers the cost of hepatitis B vaccination for those without health insurance and for other specific groups of children, including Native Americans.

The CDC estimates that infant hepatitis B vaccination saves fifty cents in direct medical costs for every dollar spent on HBV.

Comvax-Hib-HepB, a combination vaccine that protects against the Haemophilus influenzae type B bacterium and the hepatitis B virus.

Pregnant women are usually checked for Hepatitis B and syphilis.

The Hepatitis B vaccine once contained mercury, but it is now thimerosal-free.